The association between GLP-1RA use and a decreased risk of glaucoma, along with its potential implication for other neurodegenerative diseases, offers a promising avenue for targeted treatment
Sattar N, McConnachie A, Shaper AG, Blauw GJ, Buckley BM, de Craen AJ, Ford I, Forouhi NG, Freeman DJ, Jukema JW, Lennon L, Macfarlane PW, Murphy MB, Packard CJ, Stott DJ, Westendorp RG, Whincup PH, Shepherd J, Wannamethee SG
Similar content being viewed by others Introduction Cervical cancer remains a formidable global health challenge, with over 600,000 new cases and more than 340,000 deaths annually, disproportionately affecting women in low- and middle-income countries [1]
Most cosmetic skin-whitening agents use tyrosinase inhibitors such as hydroquinone, arbutin, Kojic acid, and other active ingredients
Understanding these terms helps clinicians diagnose and treat pigmentation disorders or related cancers effectively
It plays a vital role in numerous biological processes, including: Detoxification : Glutathione binds to toxins and harmful compounds, facilitating their excretion from the body